These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 29946874)
41. Perioperative bridging interruption with heparin for the patient receiving long-term anticoagulation. Spyropoulos AC; Turpie AG Curr Opin Pulm Med; 2005 Sep; 11(5):373-9. PubMed ID: 16093808 [TBL] [Abstract][Full Text] [Related]
42. [Management of NOAK administration during invasive or surgical interventions : When and how to pause and when to restart?]. Buerke M; Hoffmeister HM Med Klin Intensivmed Notfmed; 2017 Mar; 112(2):105-110. PubMed ID: 28074293 [TBL] [Abstract][Full Text] [Related]
43. [From heparin to apixaban: anticoagulants cut both ways?]. Hartung K; Meyer F; Bock F; Isermann B Zentralbl Chir; 2014 Feb; 139(1):89-97. PubMed ID: 23460104 [TBL] [Abstract][Full Text] [Related]
45. [Bridging, interruption and switching of anticoagulants in trauma surgery]. Schellong SM; Haas S; Siebenlist S Unfallchirurg; 2010 Nov; 113(11):901-7. PubMed ID: 21069507 [TBL] [Abstract][Full Text] [Related]
46. Stroke prevention versus bleeding risk of vitamin-K antagonists: a double-edged sword in patients with atrial fibrillation who require surgery. Dobrev D; Goette A; Ravens U Cardiovasc Ther; 2009; 27(4):223-5. PubMed ID: 19903184 [TBL] [Abstract][Full Text] [Related]
47. Reduced-dose warfarin or interrupted warfarin with heparin bridging for pacemaker or defibrillator implantation: a randomized trial. Schulman S; Healey JS; Douketis JD; Delaney J; Morillo CA Thromb Res; 2014 Oct; 134(4):814-8. PubMed ID: 25127655 [TBL] [Abstract][Full Text] [Related]
48. Standardized low-molecular-weight heparin bridging regimen in outpatients on oral anticoagulants undergoing invasive procedure or surgery: an inception cohort management study. Pengo V; Cucchini U; Denas G; Erba N; Guazzaloca G; La Rosa L; De Micheli V; Testa S; Frontoni R; Prisco D; Nante G; Iliceto S; Circulation; 2009 Jun; 119(22):2920-7. PubMed ID: 19470892 [TBL] [Abstract][Full Text] [Related]
49. Predictors of oral cavity bleeding and clinical outcome after dental procedures in patients on vitamin K antagonists. A cohort study. Biedermann JS; Rademacher WMH; Hazendonk HCAM; van Diermen DE; Leebeek FWG; Rozema FR; Kruip MJHA Thromb Haemost; 2017 Jun; 117(7):1432-1439. PubMed ID: 28405671 [TBL] [Abstract][Full Text] [Related]
50. Low-molecular-weight-heparins as periprocedural anticoagulation for patients on long-term warfarin therapy: a standardized bridging therapy protocol. Jaffer AK; Ahmed M; Brotman DJ; Bragg L; Seshadri N; Qadeer MA; Klein A J Thromb Thrombolysis; 2005 Aug; 20(1):11-6. PubMed ID: 16133889 [TBL] [Abstract][Full Text] [Related]
51. Influence of periprocedural anticoagulation strategies on complication rate and hospital stay in patients undergoing catheter ablation for persistent atrial fibrillation. Gunawardene M; Willems S; Schäffer B; Moser J; Akbulak RÖ; Jularic M; Eickholt C; Nührich J; Meyer C; Kuklik P; Sehner S; Czerner V; Hoffmann BA Clin Res Cardiol; 2017 Jan; 106(1):38-48. PubMed ID: 27435077 [TBL] [Abstract][Full Text] [Related]
52. Bridging evidence-based practice and practice-based evidence in periprocedural anticoagulation. Gallego P; Apostolakis S; Lip GY Circulation; 2012 Sep; 126(13):1573-6. PubMed ID: 23008469 [No Abstract] [Full Text] [Related]
53. Vitamin K antagonists for stroke prevention in hemodialysis patients with atrial fibrillation: A systematic review and meta-analysis. Van Der Meersch H; De Bacquer D; De Vriese AS Am Heart J; 2017 Feb; 184():37-46. PubMed ID: 27892885 [TBL] [Abstract][Full Text] [Related]
54. Vitamin K antagonists or low-molecular-weight heparin for the long term treatment of symptomatic venous thromboembolism. van der Heijden JF; Hutten BA; Büller HR; Prins MH Cochrane Database Syst Rev; 2002; (1):CD002001. PubMed ID: 11869618 [TBL] [Abstract][Full Text] [Related]
59. American Society of Hematology 2018 guidelines for management of venous thromboembolism: optimal management of anticoagulation therapy. Witt DM; Nieuwlaat R; Clark NP; Ansell J; Holbrook A; Skov J; Shehab N; Mock J; Myers T; Dentali F; Crowther MA; Agarwal A; Bhatt M; Khatib R; Riva JJ; Zhang Y; Guyatt G Blood Adv; 2018 Nov; 2(22):3257-3291. PubMed ID: 30482765 [TBL] [Abstract][Full Text] [Related]
60. Effects of peri-operative bridging with low molecular weight heparins on coagulation during interruption of vitamin K antagonists: A mechanistic study. Eijgenraam P; Ten Cate H; Henskens Y; van den Ham R; Ten Cate-Hoek A Thromb Res; 2016 Apr; 140():59-65. PubMed ID: 26901851 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]